These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 887744)

  • 1. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone scanning and plasma phosphatases in carcinoma of the prostate.
    O'Donoghue EP; Constable AR; Sherwood T; Stevenson JJ; Chisholm GD
    Br J Urol; 1978 May; 50(3):172-7. PubMed ID: 753455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of skeletal metastases in prostatic cancer using gamma camera (author's transl)].
    Langhammer H; Sintermann R; Kempken K; Hör G; Pabst HW; Fendl M
    Med Klin; 1977 May; 72(21):942-51. PubMed ID: 875870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of serum acid phosphatases, conventional x-ray diagnosis, bone biopsy and Sr 85-bone scanning in the diagnosis of osseous metastases in cancer of the prostate].
    Graber P; Rutishauser G; Baumann JM
    Urologe; 1971 Mar; 10(2):60-2. PubMed ID: 5577980
    [No Abstract]   [Full Text] [Related]  

  • 5. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.
    Schaffer DL; Pendergrass HP
    Radiology; 1976 Nov; 121(2):431-4. PubMed ID: 981622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bone scanning in the assessment of prostatic carcinoma.
    McGregor B; Tulloch AG; Quinlan MF; Lovegrove F
    Br J Urol; 1978 May; 50(3):178-81. PubMed ID: 753456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
    Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
    Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative x-ray, scintigraphic and clinico-chemical studies for the demonstration of bone metastases in prostatic carcinoma].
    Georgi P; Stöhrer M; Beduhn D; Clorius J
    Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:97-8. PubMed ID: 4366568
    [No Abstract]   [Full Text] [Related]  

  • 10. Skeletal scintigraphy. The use of technetium 99M-labeled complexes in the detection of early osseous involvement by metastatic tumors.
    Hopkins GB; Kristensen KA; Campbell CG
    West J Med; 1974 Jun; 120(6):448-51. PubMed ID: 4845922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An evaluation of the 99mTc-Sn-polyphosphate or 99mTc-Sn-pyrophosphate scintigraphy for the detection of bone metastases from prostatic carcinoma (author's transl)].
    Miki M; Machida T; Irikura H; Ueda M; Kido A
    Nihon Hinyokika Gakkai Zasshi; 1974 Mar; 65(3):147-57. PubMed ID: 4369483
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
    Reikerås O; Due J; Sundsfjord JA
    Int Urol Nephrol; 1988; 20(1):51-4. PubMed ID: 3283071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
    Vihko P; Heikkilä J; Kontturi M; Wahlberg L; Vihko R
    Ann Clin Res; 1984; 16(1):51-2. PubMed ID: 6742767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isotope and radiological investigations in the radiotherapy of carcinoma of the prostate (author's transl)].
    Robillard J; Cheguillaume J; Couette JE; Van Hoa L; Le Mouel M
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):804-6. PubMed ID: 4452961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bone scintigraphy, plasma ALP, TAP and PAP in patients with prostatic cancer].
    Imamura A; Hoshi H; Jinnouchi S; Samejima M; Watanabe K
    Kaku Igaku; 1988 Feb; 25(2):177-81. PubMed ID: 3386031
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial bone scanning: the assessment of treatment response in carcinoma of the prostate.
    Fitzpatrick JM; Constable AR; Sherwood T; Stephenson JJ; Chisholm GD; O'Donoghue EP
    Br J Urol; 1978 Dec; 50(7):555-61. PubMed ID: 753508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary hydroxyproline in healthy patients and in prostate patients with and without bone metastases.
    Heller W; Harzmann R; Bichler KH; Schmidt K
    Curr Probl Clin Biochem; 1979; (9):249-56. PubMed ID: 446076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
    Casetta G; Gamba P; Piana P; Pecchio F; Tizzani A
    Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone scan: in clinical perspective.
    Bisson J; Vickers M; Fagan WT
    J Urol; 1974 May; 111(5):665-9. PubMed ID: 4823975
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis of bone metastasis in prostatic carcinoma. Evaluation of x-ray, scintigraphic and biochemical methods].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Helv Chir Acta; 1977 Jun; 44(3):271-5. PubMed ID: 213402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.